Navigation Links
Immunology expert at Children's Hospital receives APS prize for patient-oriented research
Date:11/19/2009

A pediatric immunologist at The Children's Hospital of Philadelphia has received a prestigious annual award from the American Philosophical Society, an organization founded in 1743 by Benjamin Franklin. Jordan S. Orange, M.D., Ph.D., received the Society's Judson Daland Prize on Nov. 13 for his contributions to research and treatment of inherited immune deficiency diseases.

The Judson Daland Prize for Clinical Investigation recognizes outstanding achievements in patient-oriented research. Honorees are nominated by chairs of clinical departments at a U.S. medical school or hospital and selected by a distinguished committee of biomedical researchers.

Dr. Orange's work involves the innate immune system, the body's first defense against life-threatening infections and diseases. His particular research focus is natural killer cells, a major component of the innate immune system, which have an inherent ability to destroy cancer or virus-infected cells. While in graduate school at Brown University, he discovered that natural killer cells produce cytokines, which are secreted immune signaling molecules, to participate in defending the body against viruses.

Dr. Orange has continued his research in natural killer cells as a pediatrician, defining the field of human diseases caused by inherent deficiencies of natural killer cells. These include diseases in which only natural killer cells are defective, or where they are defective along with other components of immunity.

One example is Wiskott-Aldrich syndrome, a difficult to treat, life-threatening, immune-deficiency disease. Dr. Orange discovered a natural killer cell defect and its mechanism in these patients, which make them especially vulnerable to herpesvirus infections and blood cell cancers. He used this knowledge to develop a novel therapy that bypasses the cellular defect, and has begun a unique clinical trial of the treatment at The Children's Hospital of Philadelphia.

In addition to his laboratory research at Children's Hospital, Dr. Orange evaluates and cares for children with primary immunodeficiency diseases, a varied and complex group of disorders resulting from a congenital defect in some component of the immune system. Though it results in recurrent or severe infections, the child's underlying disease may go undiscovered for years until he or she receives an accurate diagnosis and appropriate treatment. Establishing an accurate diagnosis and providing therapy can dramatically improve outcome in these diseases and often provides a child with a relatively normal childhood and adult life.

Dr. Orange received the Daland Prize, including a $10,000 honorarium, during an award presentation on Nov. 13, at the American Philosophical Society's headquarters in center city Philadelphia. The prize commemorates Judson Daland, a prominent Philadelphia physician and medical researcher, who left a bequest to the Society to support clinical research. As part of that fund, the Society has awarded Judson Daland Fellowships since 1938, and established the annual prize in 2001.


'/>"/>

Contact: Rachel Salis-Silverman
Salis@email.chop.edu
267-426-6063
Children's Hospital of Philadelphia
Source:Eurekalert  

Related medicine news :

1. MedImmune Announces Winners of the 4th Respiratory, Immunology and Autoimmunity Research Abstract Competition
2. NIAID announces new human immunology research awards to help fight emerging infectious diseases
3. Karmanos Cancer Institute Immunology Researcher Obtains Nearly $1 Million National Institutes of Health Grant
4. New Federal Training Grant to Teach Doctors/Scientists Immunology
5. Immunology Center will continue to drive standard methods, better science
6. A*STARs Singapore Immunology Network Is the First GeneGo Center of Excellence in Asia
7. Nations top experts in psychoneuroimmunology to gather Sept 18-21 in Tampa, Fla.
8. The Journal of Allergy and Clinical Immunology devotes special issue to AIDS
9. CEL-SCI Presents Favorable Data for Leaps Vaccine Technology at Prestigious Immunology Conference
10. World-Renowned Scientists to Lead Immunology Course
11. Menopausal Women May Have an Increased Asthma Risk, From The Journal of Allergy and Clinical Immunology
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Immunology expert at Children's Hospital receives APS prize for patient-oriented research
(Date:10/13/2017)... , ... October 13, 2017 , ... ... serving communities in the greater Dallas, Miami, and Raleigh regions, is organizing an ... to overcome a rare and deadly chromosome abnormality. , After struggling since birth ...
(Date:10/13/2017)... ... , ... As health professionals work to improve their approach to healthcare, there ... more than filling out a survey; in many cases health professionals and patients are ... care and research on the importance of active engagement with patients and members of ...
(Date:10/13/2017)... ... October 13, 2017 , ... The American Board of Family Medicine's ... President and Chief Executive Officer, succeeding Dr. James C. Puffer upon his retirement. Dr. ... 2018 until Dr. Puffer’s retirement at the end of 2018. Upon assuming the role ...
(Date:10/13/2017)... ... October 13, 2017 , ... PurhealthRX , a leading Health and ... Applying the Purzorb™process to full spectrum CBD oil will revolutionize the rapidly growing CBD ... that can be easily incorporated into liquid products, while reducing costs to end users. ...
(Date:10/13/2017)... ... October 13, 2017 , ... Lori R. Somekh, founder of the ... a national organization of elder law and special needs planning attorneys. “Membership in ElderCounsel ... also provides a forum to network with elder law attorneys nationwide,” said Somekh. ...
Breaking Medicine News(10 mins):
(Date:10/2/2017)... , Oct. 2, 2017  Eli Lilly and ... financial results for the third quarter of 2017 on ... conference call on that day with the investment community ... The conference call will begin at 9 ... can access a live webcast of the conference call ...
(Date:9/28/2017)... 28, 2017 Hill-Rom Holdings, Inc. (NYSE: HRC), ... call and webcast on Friday, November 3, 2017, beginning ... ending at approximately 8:30 a.m. (CDT) / 9:30 a.m. ... 2017 financial performance and guidance for 2018, Hill-Rom executives ... enhance operational performance, and long-range financial outlook through 2020. ...
(Date:9/25/2017)... 25, 2017   Montrium , an industry ... today—from the IQPC Trial Master Files & Inspection ... that EastHORN Clinical Services has selected eTMF ... TMF management. EastHORN, a leading European contract research ... increase transparency to enable greater collaboration with sponsors, ...
Breaking Medicine Technology: